Compare DUOL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOL | SNN |
|---|---|---|
| Founded | 2011 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 14.0B |
| IPO Year | 2021 | 1999 |
| Metric | DUOL | SNN |
|---|---|---|
| Price | $198.73 | $33.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 4 |
| Target Price | ★ $330.67 | $32.83 |
| AVG Volume (30 Days) | ★ 2.0M | 476.9K |
| Earning Date | 11-05-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | ★ 338.81 | 59.91 |
| EPS | ★ 8.04 | 0.56 |
| Revenue | $964,271,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $40.50 | $7.78 |
| Revenue Next Year | $22.65 | $5.13 |
| P/E Ratio | ★ $24.86 | $29.10 |
| Revenue Growth | ★ 39.86 | 5.35 |
| 52 Week Low | $166.27 | $23.69 |
| 52 Week High | $544.93 | $38.79 |
| Indicator | DUOL | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 48.01 |
| Support Level | $181.20 | $32.68 |
| Resistance Level | $194.20 | $33.56 |
| Average True Range (ATR) | 8.61 | 0.41 |
| MACD | 6.46 | 0.14 |
| Stochastic Oscillator | 93.92 | 78.51 |
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.